Movano Inc. (NASDAQ:MOVE) Short Interest Update

Movano Inc. (NASDAQ:MOVE) saw a large decline in short interest in the month of January. As of January 15th, there was short interest totaling 25,442 shares, a decline of 41.4% from the December 31st total of 43,438 shares. Based on an average trading volume of 29,466 shares, the days-to-cover ratio is presently 0.9 days. Approximately 3.4% of the company’s shares are sold short. Approximately 3.4% of the company’s shares are sold short. Based on an average trading volume of 29,466 shares, the days-to-cover ratio is presently 0.9 days.

Movano Stock Down 10.2%

MOVE stock traded down $1.94 during trading on Friday, hitting $17.13. 189,388 shares of the company’s stock traded hands, compared to its average volume of 2,889,920. The firm has a market capitalization of $14.22 million, a P/E ratio of -1.58 and a beta of 0.79. Movano has a 1 year low of $4.67 and a 1 year high of $55.00. The business has a fifty day simple moving average of $9.56 and a two-hundred day simple moving average of $8.05.

Movano (NASDAQ:MOVE) last announced its earnings results on Friday, November 14th. The technology company reported ($4.73) earnings per share (EPS) for the quarter, beating the consensus estimate of ($7.00) by $2.27. Movano had a negative return on equity of 647.91% and a negative net margin of 3,409.60%.The business had revenue of $0.08 million for the quarter, compared to analysts’ expectations of $3.88 million.

Insider Activity at Movano

In other Movano news, CTO Michael Aaron Leabman sold 6,845 shares of the company’s stock in a transaction on Wednesday, January 14th. The stock was sold at an average price of $6.66, for a total value of $45,587.70. Following the transaction, the chief technology officer owned 22,639 shares of the company’s stock, valued at $150,775.74. This represents a 23.22% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CEO John Mastrototaro sold 33,069 shares of Movano stock in a transaction on Tuesday, January 27th. The stock was sold at an average price of $20.80, for a total value of $687,835.20. Following the sale, the chief executive officer owned 56,114 shares of the company’s stock, valued at approximately $1,167,171.20. This trade represents a 37.08% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 94,383 shares of company stock worth $1,524,933 in the last quarter. 10.40% of the stock is owned by company insiders.

Institutional Trading of Movano

A hedge fund recently bought a new stake in Movano stock. Citadel Advisors LLC acquired a new position in shares of Movano Inc. (NASDAQ:MOVE) in the 3rd quarter, according to the company in its most recent filing with the SEC. The fund acquired 49,262 shares of the technology company’s stock, valued at approximately $28,000. Citadel Advisors LLC owned approximately 5.94% of Movano as of its most recent SEC filing. 16.64% of the stock is currently owned by institutional investors and hedge funds.

Movano News Summary

Here are the key news stories impacting Movano this week:

• Positive Sentiment: Short interest has fallen substantially in January, reducing one pool of bearish pressure and the chance of disorderly short?covering volatility later.
• Positive Sentiment: Technical: the stock recently cleared its 200?day moving average — a bullish technical milestone that can attract momentum buyers. Movano 200?Day MA Article
• Neutral Sentiment: Liquidity/volatility: trading has seen multiple intraday LULD pauses and lower?than?average volume today, meaning price swings can be amplified by lighter order flow.
• Negative Sentiment: Insider selling: CEO John Mastrototaro sold 33,069 shares (~37% reduction in his holdings) at about $20.80. Filing: CEO SEC Filing
• Negative Sentiment: Insider selling: CFO Jeremy Cogan sold 28,736 shares (~32% reduction) at about $20.78. Filing: CFO SEC Filing
• Negative Sentiment: Fundamentals remain challenged: the company’s last quarter showed a sizable EPS beat on an accounting basis but essentially no revenue (reported $0.08M vs. consensus ~$3.9M) and extreme negative margins/ROE — keeps investor focus on cash burn and path to meaningful sales.
• Negative Sentiment: Analyst sentiment is weak: recent notes include downgrades / reiterated sell ratings from independent outlets, which can pressure the stock in a thin market. Weiss Ratings

Analyst Upgrades and Downgrades

A number of equities analysts have commented on the stock. Weiss Ratings restated a “sell (e+)” rating on shares of Movano in a research note on Thursday, January 22nd. Wall Street Zen lowered Movano from a “hold” rating to a “sell” rating in a report on Saturday, January 17th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company presently has a consensus rating of “Sell”.

Movano Company Profile

Movano Health, Inc (NASDAQ: MOVE) is a health technology company focused on developing wearable devices for continuous biometric monitoring. The company’s core mission is to provide accessible, real-time health insights through noninvasive sensors, enabling individuals and care teams to track vital signs and physiological trends outside of traditional clinical settings.

Movano’s flagship product is a biometric monitoring ring designed to measure parameters such as heart rate, blood oxygen saturation, skin temperature, and sleep quality.